Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Pregnancies complicated by diabetes and mild gestational hyperglycemia are associated with increased perinatal and maternal complications. The most serious maternal complication is the risk of developing type 2 diabetes after 10-12 years of the delivery. Perinatal complications include fetal macrosomia with consequent increased risk of obstetrical trauma and hypoxia/asphyxia, high rates of cesarean section, respiratory distress syndrome, and metabolic disorders at birth. Regardless of the diagnosis of diabetes and mild gestational hyperglycemia, the perinatal outcome is directly related to maternal metabolic control. For the tight control of blood glucose, pregnant women are treated as home care (outpatient) or hospital care. Objective: To evaluate the cost-effectiveness and safety of home versus hospital care of gestational diabetes and mild gestational hyperglycemia.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Home care | Experimental |
| |
| Hospital care | Active Comparator |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Home care | Other | Home care, sometimes called "ambulatory care" or "outpatient", was defined as the blood-glucose self-monitored by the pregnant women at home. This project will provide glucometers to all those who are randomized to home care. The women will receive training for glucose control in pre-defined days, with the glucometer to obtain the mean glucose. According to blood-glucose levels in glycemic profile, insulin dose will be maintained or altered both in gestational diabetes as in mild gestational hyperglycemia . |
| Measure | Description | Time Frame |
|---|---|---|
| Maternal mortality and morbidity rates | participants will be followed regarding maternal and perinatal mortality and morbidity rates up to six weeks postnatal | |
| Perinatal mortality and morbidity rates | participants will be followed regarding maternal and perinatal mortality and morbidity rates up to six weeks postnatal |
| Measure | Description | Time Frame |
|---|---|---|
| Birth weight (classified as appropriate for gestational age = AIG, small for gestational age =SGA and large for gestational age = LGA) | birth weight will be assessed for an expected average of 9 months from the time of randomization | |
| Maternal hospitalizations for any causes (home care) and prolonged hospitalization (hospital care) |
Not provided
Inclusion Criteria:
Patients who were diagnosed with gestational, pre gestational diabetes mellitus or mild gestational hyperglycemia. Patients should have one of the four criteria as following:
Patients with positive screening for GDM presenting a TTG of 75 g and one of the values below:
Patients with pre gestational diabetes mellitus type 1 or 2; or
Patients with positive screening for GDM and presenting normal TTG of 75 g and abnormal glycemic profile, fasting ≥ 85 mg k/l 10 h to 18h post prandial ≥ 130 mg k/ ( Rudge et al,1990).
Normal TTG and an abnormal glycemic profile will be considered as mild gestational hyperglycemia
Patient provided written informed consent.
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Dr Regina El Dib, PhD | UPECLIN HC FM Botucatu Unesp | Study Director |
| Dr Marilza Rudge, PhD | UPECLIN HC FM Botucatu Unesp | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Faculdade de Medicina de Botucatu, Universidade Estadual Paulista | Botucatu | São Paulo | 18618-970 | Brazil |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Hospital care | Other | Hospital care, sometimes called "acute care", was defined as control of maternal diabetes made at hospitals by admission to hospital. The blood-glucose and metabolic control are done in gestational diabetes and mild gestational hyperglycemia treated conventionally. The hospitalized patients will have their glycemic control done in the hospital. . According to blood-glucose levels in glycemic profile , insulin dose will be maintained or altered both in gestational diabetes as in mild gestational hyperglycemia. All the women of the study will be accompanied by a team of obstetricians specializing in high-risk pregnancies; residents; dietitians; nurses and neonatologists. |
|
| participants will be followed for maternal hospitalizations for any causes and prolonged hospitalization up to six weeks postnatal |
| Infants repeated hospitalizations | infants will be followed for repeated hospitalizations up to six weeks postnatal |
| Infants acute care visits | infants will be followed for acute care visits up to six weeks postnatal |
| Length of stay for delivery | participants will be followed for length of stay for delivery, an expected average of 9 months |
| Maternal prenatal and postpartum acute care visits | participants will be followed for maternal prenatal and postpartum acute care visits up to six weeks postnatal |
| Biophysical profile tests | participants will be followed for biophysical profile tests up to six weeks postnatal |
| Incidence of premature infants | participants will be followed regarding incidence of premature infants up to six weeks postnatal |
| Postpartum repeated hospitalization | participants will be followed for Postpartum repeated hospitalization up to six weeks postnatal |
| Glucose control | participants will be followed for glucose control up to six weeks postnatal |
| Costs | costs will be assessed for an expected average of 9 months from the time of randomization |
| ID | Term |
|---|---|
| D016640 | Diabetes, Gestational |
| ID | Term |
|---|---|
| D011248 | Pregnancy Complications |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D003920 | Diabetes Mellitus |
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
| D004700 | Endocrine System Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D006699 | Home Care Services |
| ID | Term |
|---|---|
| D003153 | Community Health Services |
| D006296 | Health Services |
| D005159 | Health Care Facilities Workforce and Services |
| D009739 | Nursing Services |
Not provided
Not provided